InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
3
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-37.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Chevallard Daniel R., Chief Financial Officer. Insider active across 3 companies, notably Viracta Therapeutics, Inc.. In total, 16 filings have been published. Breakdown: 3 buys · 1 sell. Total volume traded: €104k. History available since 28 May 2021. The latest transaction was filed on 27 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Chevallard Daniel R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
7,500 shares@ US$8.5754.7% of flowCommon StockSEC:0001706176-26-000004:0
Canonical exit: 25 Jun 2026 (T+90)
20 shares@ US$22.710.4% of flowCommon StockSEC:0001815776-25-000072:0
Canonical exit: 5 Feb 2026 (T+90)
3,188 shares@ US$15.68100.0% of flowCommon StockSEC:0001815776-24-000046:0
Canonical exit: 12 Aug 2024 (T+90)
6,889 shares0Common StockSEC:0001209191-24-004037:0
3,720 shares@ US$0.509.3% of flowCommon StockSEC:0001209191-23-056842:1
6,889 shares0Common StockSEC:0001209191-23-056842:0
6,888 shares0Common StockSEC:0001209191-23-047665:0
6,889 shares0Common StockSEC:0001209191-23-032707:0
6,889 shares0Common StockSEC:0001209191-23-013854:0
6,889 shares0Common StockSEC:0001209191-22-058981:0
6,889 shares0Common StockSEC:0001209191-22-047948:0
6,889 shares0Common StockSEC:0001209191-22-032665:0
6,889 shares0Common StockSEC:0001209191-22-014438:0
13,777 shares0Common StockSEC:0001209191-21-067045:0
10,000 shares@ US$0.9042.2% of flowCommon StockSEC:0001209191-21-058099:0
12,000 shares@ US$0.9048.5% of flowCommon StockSEC:0001209191-21-036907:0
16 of 16 declarations
About Chevallard Daniel R.
Chevallard Daniel R. is Directeur Financier. He has 16 filings in total. In the recent sampled filings we hold, buys total EUR 102337 and sells total EUR 1697, over the period from 2021-06-01 to 2026-03-30. The companies cited are Viracta Therapeutics, Inc. and LENZ Therapeutics, Inc., and the most frequent transaction nature is Levée d'options.
